Maiyata Microbial Inspection Intelligent Technology

Explore the latest insights on Maiyata Microbial Inspection Intelligent Technology and its impact on China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data, news, and intelligence to help you navigate the complexities of Maiyata Microbial Inspection Intelligent Technology’s developments with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Shandong Lukang Wins NMPA Registration for Generic Cefuroxime Sodium for Injection – Entering a RMB 2.6 Billion Chinese Cephalosporin Market
CompanyDrug

Shandong Lukang Wins NMPA Registration for Generic Cefuroxime Sodium for Injection – Entering a RMB 2.6 Billion Chinese Cephalosporin Market

Shandong Lukang Pharmaceutical Co., Ltd. (SHA: 600789) announced that it has received Drug Registration Certificates (Certificate Nos. 2026S03571 and 2026S03572) from China's National Medical Products Administration (NMPA) for Cefuroxime Sodium…

Xunfei Healthcare Establishes Hainan Xunfei Internet Hospital Subsidiary with RMB 10 Million Registered Capital – Extending Digital Healthcare Footprint in Hainan Free Trade Port

Xunfei Healthcare Establishes Hainan Xunfei Internet Hospital Subsidiary with RMB 10 Million Registered Capital – Extending Digital Healthcare Footprint in Hainan Free Trade Port

CSPC's Recombinant Herpes Zoster Vaccine SYS6052 Clears U.S. FDA IND – Company's First Recombinant Protein Vaccine Candidate to Enter Clinical Trials

CSPC’s Recombinant Herpes Zoster Vaccine SYS6052 Clears U.S. FDA IND – Company’s First Recombinant Protein Vaccine Candidate to Enter Clinical Trials

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Boji Medical and Zhejiang Maiyata Sign Strategic Partnership – Leading China CRO Joins Microbiome Innovator to Advance Live Biotherapeutic Products
CompanyDeals

Boji Medical and Zhejiang Maiyata Sign Strategic Partnership – Leading China CRO Joins Microbiome Innovator to Advance Live Biotherapeutic Products